Aging And Wellness Trends Will Boost Med Tech Amid Risks
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
09 May 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
US$21.00
29.5% undervalued intrinsic discount20 Aug
US$14.81
1Y
-8.9%7D
3.2%